SCHEMBL20219322

SCHEMBL20219322

C=Cc1ncc(OCCOc2cccc(OC)c2OC)c(NCCCC)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 5/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ TLR7 Q9NYK1 4/20 0.39
▸ TLR8 Q9NR97 2/20 0.39
▸ UTS2R Q9UKP6 1/20 0.38
▸ FLT3 P36888 2/20 0.37
▸ STK17A Q9UEE5 1/20 0.36
▸ GBA1 P04062 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ HTR1A P08908 1/20 0.34
▸ ADRA1D P25100 1/20 0.34
▸ ADRA1A P35348 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23472437 0.86 KMT2A (0.37) CYP1A2CYP3A4TLR7TLR8STK17A
SCHEMBL23472466 0.85 CYP1A2 (0.45) CYP1A2CYP3A4TLR7TLR8UTS2R
SCHEMBL15470025 0.84 CYP1A2 (0.53) CYP1A2CYP3A4TLR7TLR8CYP2D6
SCHEMBL20219428 0.80 TLR7 (0.40) CYP1A2CYP3A4TLR7TLR8FLT3
SCHEMBL23472434 0.80 CYP2D6 (0.40) CYP1A2CYP3A4TLR7TLR8FLT3
SCHEMBL23472423 0.80 MEN1 (0.45) SMN1; SMN2MEN1KMT2AALDH1A1NPC1
SCHEMBL23472511 0.79 CHRNB2 (0.43) CYP1A2CYP3A4TLR7TLR8GBA1
SCHEMBL23472425 0.78 CASP6 (0.41) CYP1A2CYP3A4TLR7TLR8UTS2R
SCHEMBL20219702 0.78 ALDH1A1 (0.35) TLR7TLR8MEN1KMT2AALDH1A1
SCHEMBL20219444 0.77 TLR7 (0.42) CYP1A2CYP3A4TLR7TLR8FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330257-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS Janssen Sciences Ireland UC (IE) 2018-06-06 — — EP disclosed
Send feedback